HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Q1

This article was originally published in The Rose Sheet

Executive Summary

Americas region generated underlying growth of 6.8% to $3.93 bil., Unilever reports during a May 6 earnings call. The performance was boosted by the home and personal care segment in the U.S., specifically deodorants, hair care and personal wash, as well as strength of the prestige unit, the firm says. Operating profit in the Americas region advanced 7.2% at constant rates to $599 mil. Unilever's personal care segment had underlying sales growth of 8.8% in Q1 to $3.27 bil.; the strongest growth in the sector in six quarters, company notes. Sales were driven by personal wash brands in North America and Asia, deodorant brands Axe, Rexona and Dove, and continued momentum of prestige sector. The firm also announces it has appointed a team to conduct a review of Unilever's corporate structure, with non-executive chairman Antony Burgmans leading the effort. A largescale management reorganization was announced in February (1"The Rose Sheet" Feb. 14, 2005, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel